Prelude Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Prelude Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,810	Closed	-$75K	–	2298
2019 Q4	$75K	Buy	+18,810	New	+$88.4K	﹤0.01%	1212
2019 Q3	–	Sell	-2,066	Closed	-$13K	–	2253
2019 Q2	$13K	Buy	+2,066	New	+$11K	﹤0.01%	1357
2018 Q4	–	Sell	-96	Closed	-$1.62K	–	2345
2018 Q3	$2K	Sell	96 -82	-46%	-$1.75K	﹤0.01%	1678
2018 Q2	$5K	Buy	+178	New	+$4.15K	﹤0.01%	1564
2017 Q3	–	Sell	-2,405	Closed	-$36K	–	2022
2017 Q2	$36K	Buy	+2,405	New	+$40.1K	﹤0.01%	1104
2016 Q3	–	Sell	-2,627	Closed	-$88.2K	–	1929
2016 Q2	$92K	Sell	2,627 -4,037	-61%	-$127K	0.01%	795
2016 Q1	$183K	Buy	6,664 +857	+15%	+$25.2K	0.03%	585
2015 Q4	$199K	Buy	+5,807	New	+$181K	0.03%	574

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Prelude Capital Management's DPLO Position: Q1 2020 in Review

Prelude Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 18,810 shares — an estimated $75K sold.

Prelude Capital Management first reported a position in DPLO in Q4 2015 and held it in 8 quarters. The position peaked at $199K in Q4 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Prelude Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Prelude Capital Management sold 18,810 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $75K.
Prelude Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 8 quarters.
Prelude Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $199K in Q4 2015.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.